SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000927016-03-001602
Filing Date
2003-04-02
Accepted
2003-04-02 16:42:32
Documents
2
Period of Report
2003-05-08
Effectiveness Date
2003-04-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 243875
3 GRAPHIC g94593g18s12.jpg GRAPHIC 206066
  Complete submission text file 0000927016-03-001602.txt   451675
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-10824 | Film No.: 03637143
SIC: 2835 In Vitro & In Vivo Diagnostic Substances